We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
+14.25%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$966M
AUM Growth
+$269M
Cap. Flow
+$319M
Cap. Flow %
33.08%
Top 10 Hldgs %
49.6%
Holding
104
New
32
Increased
25
Reduced
14
Closed
27

Top Buys

Rank Stock Value
1
SNN icon
Smith & Nephew
SNN
+$27.6M
2
RIGL icon
Rigel Pharmaceuticals
RIGL
+$20.3M
3
SIBN icon
SI-BONE Inc
SIBN
+$18.8M
4
NTRA icon
Natera
NTRA
+$14.1M
5
JSPR icon
Jasper Therapeutics
JSPR
+$13.8M

Top Sells

Rank Stock Value
1
CVRX icon
CVRx
CVRX
+$18.6M
2
VCEL icon
Vericel Corp
VCEL
+$16.9M
3
LLY icon
Eli Lilly
LLY
+$14.3M
4
HCA icon
HCA Healthcare
HCA
+$8.29M
5
KRYS icon
Krystal Biotech
KRYS
+$8.09M

Sector Composition

Rank Sector Weight
1 Healthcare 81.2%
2 Consumer Staples 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELL
101
DELISTED
PhenomeX Inc. Common Stock
CELL
– –
-1,330,000
Closed -$3.56M
KDNY
102
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-78,000
Closed -$2.04M
RXDX
103
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-31,100
Closed -$3.42M
IMGO
104
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
– –
-115,000
Closed -$4.13M
1 2 3 4
5

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return

Soleus Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Soleus Capital Management held 104 positions worth $966M, up 39% from $697M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Soleus Capital Management deployed $319M of net new capital in Q1 2023, opening 32 new positions and adding to 25 existing holdings. Its largest new stake was Smith & Nephew: 970,200 shares worth $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 97% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Vericel Corp, an estimated $16.9M trimmed.

  • Soleus Capital Management's largest Q1 2023 buy was Smith & Nephew: 970,200 shares worth $27.1M.
  • Soleus Capital Management added most to CVS Health in Q1 2023, an estimated $12.5M increase.
  • Soleus Capital Management's biggest Q1 2023 reduction was Vericel Corp, cutting an estimated $16.9M.
  • Soleus Capital Management fully exited CVRx in Q1 2023, selling an estimated $18.6M.
  • Soleus Capital Management's ten largest holdings make up 50% of its $966M portfolio in Q1 2023.
  • Soleus Capital Management opened 32 new positions and closed 27 in Q1 2023.
  • Soleus Capital Management's portfolio value rose 39% quarter-over-quarter to $966M.

Based on Soleus Capital Management's 13F filing for Q1 2023, filed 15 May 2023.